T. Rowe Price Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-402,521
Closed -$18.6M 564
2022
Q4
$18.6M Sell
402,521
-2,204,910
-85% -$102M 0.01% 465
2022
Q3
$108M Buy
+2,607,431
New +$108M 0.09% 228